Science Explorer Back to mapMap
Discussion
Company · Cleveland · United States

Athersys (United States)

athersys.comROR OpenAlex
Research works
78
▼ 95% vs 2018-21
Citations
4.4k
56.6 per fractional work
Top-10% rate
12.2%
all institutions 10.0%
Open access
41%
world 40%
International
23%
world 18%
Athersys (United States)

Not ranked overall: Athersys (United States) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.

Which fields of science does Athersys (United States) work in?

In all years, 53% of research at Athersys (United States) is in Health Sciences, 36% in Life Sciences. Its largest fields are Medicine (52%), Biochemistry, Genetics and Molecular Biology (22%), Neuroscience (8%). It does 2.1× the world's share of Health Sciences.

Health Sciences: 41 fractional works · 53.0% of its workMedicine: 41 fractional works · 52.3% of its workGenetics: 12 fractional works · 15.4% of its workSurgery: 6 fractional works · 8.3% of its workPhysiology: 5 fractional works · 6.0% of its workOncology: 3 fractional works · 4.5% of its workNeurology: 2 fractional works · 2.7% of its workPulmonary and Respiratory Medicine: 2 fractional works · 2.6% of its workHematology: 2 fractional works · 2.6% of its workCardiology and Cardiovascular Medicine: 1 fractional works · 1.1% of its workRehabilitation: 1 fractional works · 1.0% of its workInfectious Diseases: 1 fractional works · 0.9% of its workPublic Health, Environmental and Occupational Health: 1 fractional works · 0.8% of its workImmunology and Allergy: 1 fractional works · 0.7% of its workReproductive Medicine: 1 fractional works · 0.7% of its workPathology and Forensic Medicine: 1 fractional works · 0.7% of its workPediatrics, Perinatology and Child Health: 0 fractional works · 0.6% of its workEndocrinology, Diabetes and Metabolism: 0 fractional works · 0.6% of its workEpidemiology: 0 fractional works · 0.5% of its workHepatology: 0 fractional works · 0.5% of its workComplementary and alternative medicine: 0 fractional works · 0.4% of its workPharmacology: 0 fractional works · 0.4% of its workRadiology, Nuclear Medicine and Imaging: 0 fractional works · 0.4% of its workEmergency Medicine: 0 fractional works · 0.2% of its workOrthopedics and Sports Medicine: 0 fractional works · 0.2% of its workPsychiatry and Mental health: 0 fractional works · 0.2% of its workNursing: 0 fractional works · 0.4% of its workNutrition and Dietetics: 0 fractional works · 0.4% of its workHealth Professions: 0 fractional works · 0.3% of its workGeneral Health Professions: 0 fractional works · 0.3% of its workLife Sciences: 28 fractional works · 35.6% of its workBiochemistry, Genetics and Molecular Biology: 17 fractional works · 22.3% of its workMolecular Biology: 14 fractional works · 18.3% of its workGenetics: 2 fractional works · 1.9% of its workCancer Research: 1 fractional works · 0.7% of its workBiotechnology: 0 fractional works · 0.6% of its workBiophysics: 0 fractional works · 0.4% of its workCell Biology: 0 fractional works · 0.4% of its workNeuroscience: 6 fractional works · 7.8% of its workCellular and Molecular Neuroscience: 2 fractional works · 2.9% of its workDevelopmental Neuroscience: 2 fractional works · 2.6% of its workNeurology: 1 fractional works · 1.8% of its workEndocrine and Autonomic Systems: 0 fractional works · 0.5% of its workImmunology and Microbiology: 4 fractional works · 4.8% of its workImmunology: 4 fractional works · 4.8% of its workAgricultural and Biological Sciences: 0 fractional works · 0.5% of its workPlant Science: 0 fractional works · 0.5% of its workPharmacology, Toxicology and Pharmaceutics: 0 fractional works · 0.2% of its workToxicology: 0 fractional works · 0.2% of its workPhysical Sciences: 8 fractional works · 10.4% of its workChemistry: 4 fractional works · 5.6% of its workOrganic Chemistry: 4 fractional works · 5.1% of its workSpectroscopy: 0 fractional works · 0.4% of its workEngineering: 3 fractional works · 3.6% of its workBiomedical Engineering: 2 fractional works · 2.7% of its workIndustrial and Manufacturing Engineering: 0 fractional works · 0.6% of its workElectrical and Electronic Engineering: 0 fractional works · 0.2% of its workComputer Science: 0 fractional works · 0.6% of its workComputer Vision and Pattern Recognition: 0 fractional works · 0.6% of its workMaterials Science: 0 fractional works · 0.6% of its workBiomaterials: 0 fractional works · 0.6% of its workSocial Sciences: 1 fractional works · 1.0% of its workPsychology: 0 fractional works · 0.4% of its workClinical Psychology: 0 fractional works · 0.4% of its workSocial Sciences: 0 fractional works · 0.3% of its workEducation: 0 fractional works · 0.3% of its workEconomics, Econometrics and Finance: 0 fractional works · 0.2% of its workEconomics and Econometrics: 0 fractional works · 0.2% of its workALL ITS WORKAthersys (UnitedStates)78fractional works, all years
Life Sciences36%Physical Sciences10%Health Sciences53%Social Sciences1%

Each ring splits the one inside it: the four domains of science, their fields, their subfields. Size is fractional works in all years. Every slice is a page; the interactive view zooms down to single topics and colours each by how much more of it this institution does than the world.

Its 4 domains and 15 fields, with their numbers
    1. Medicine4152.3%
    2. Nursing00.4%
    3. Health Professions00.3%
    1. Biochemistry, Genetics and Molecular Biology1722.3%
    2. Neuroscience67.8%
    3. Immunology and Microbiology44.8%
    4. Agricultural and Biological Sciences00.5%
    5. Pharmacology, Toxicology and Pharmaceutics00.2%
    1. Chemistry45.6%
    2. Engineering33.6%
    3. Computer Science00.6%
    4. Materials Science00.6%
    1. Psychology00.4%
    2. Social Sciences00.3%
    3. Economics, Econometrics and Finance00.2%
All of science, and how each field's share has moved since 1950: the Science domain explorer

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Who are the top researchers at Athersys (United States)?

Ranked on the quality score, Robert Deans, Robert W. Mays and Anthony E. Ting lead among researchers whose main affiliation is Athersys (United States).

  1. 1 Robert Deans United States · #494,924 worldwide 13k citations · 138 works
  2. 2 Robert W. Mays United States · #496,319 worldwide 4k citations · 63 works
  3. 3 Anthony E. Ting United States · #996,218 worldwide 3.7k citations · 80 works
  4. 4 Jason A. Hamilton United States · #1,156,273 worldwide 700 citations · 23 works
  5. 5 Stephen E. Rundlett United States · #1,337,754 worldwide 1.9k citations · 20 works
  6. 6 Alice Valentin-Torres United States · #1,357,163 worldwide 738 citations · 15 works
  7. 7 R.J. Deans United States · #1,533,718 worldwide 21k citations · 38 works
  8. 8 Steven M. Murphy United States · #2,050,101 worldwide 913 citations · 20 works
  9. 9 Amy Raber United States · #2,998,644 worldwide 535 citations · 17 works
  10. 10 Nicholas Lehman United States · #3,159,301 worldwide 768 citations · 21 works
All ranked researchers at Athersys (United States)

What are the most cited papers from Athersys (United States)?

The most cited paper from Athersys (United States) is "Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement" (Massimo Dominici, Katarina Le Blanc, Ingo Mueller et al., 2006), with 18,014 citations. Next come "Clarification of the nomenclature for MSC: The International Society for Cellular Therapy position statement" (2,079) and "Formation of de novo centromeres and construction of first-generation human artificial microchromosomes" (656).

Most cited papers
#PaperReleasedCitations
1 Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement Massimo Dominici, Katarina Le Blanc, Ingo Mueller et al. · Cytotherapy 2006 18,014
2 Clarification of the nomenclature for MSC: The International Society for Cellular Therapy position statement E.M. Horwitz, Katarina Le Blanc, Massimo Dominici et al. · Cytotherapy 2005 2,079
3 Formation of de novo centromeres and construction of first-generation human artificial microchromosomes John Harrington, Gil Van Bokkelen, Robert W. Mays et al. · Nature Genetics Apr 1997 656
4 International Society for Cellular Therapy perspective on immune functional assays for mesenchymal stromal cells as potency release criterion for advanced phase clinical trials Jacques Galipeau et al. · Cytotherapy Open access 23 Dec 2015 534
5 Safety and efficacy of multipotent adult progenitor cells in acute ischaemic stroke (MASTERS): a randomised, double-blind, placebo-controlled, phase 2 trial David Charles Hess, Lawrence R. Wechsler, Wayne M. Clark et al. · The Lancet Neurology 17 Mar 2017 377
All 60 most cited papers, with filters and sorting

Which keywords describe research at Athersys (United States)?

By fractional works in all years, weighted toward what it does more of than the world: Differentiation, Mesenchymal Stem Cells, Regeneration, Transplantation, Therapeutic, Immunomodulation, Multipotent and Regenerative Medicine.

▲ more of its work than of the world's◆ about the world's share▼ less than the world's

Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 40 words, with their numbers
  1. Differentiation14▲ 247×2 topics
  2. Mesenchymal Stem Cells14▲ 151×2 topics
  3. Regeneration13▲ 91×2 topics
  4. Therapeutic12▲ 194×2 topics
  5. Transplantation12▲ 137×4 topics
  6. Immunomodulation12▲ 103×1 topic
  7. Multipotent12▲ 394×1 topic
  8. Regenerative Medicine8▲ 49×4 topics
  9. Inflammation6▲ 3.6×19 topics
  10. Extracellular Matrix5▲ 25×3 topics
  11. Stem Cell Therapy4▲ 55×2 topics
  12. Decellularization4▲ 137×1 topic
  13. Organ Engineering4▲ 137×1 topic
  14. Clinical Trials4▲ 7.8×3 topics
  15. Cancer3▲ 3.0×9 topics
  16. Brain Development3▲ 20×3 topics
  17. Neuroinflammation3▲ 14×3 topics
  18. Regulatory Challenges3▲ 51×1 topic
  19. Stem Cell Regulation3▲ 174×1 topic
  20. Immunotherapy3▲ 5.8×6 topics
  21. Cancer Immunotherapy3▲ 24×3 topics
  22. Pluripotent Stem Cells3▲ 48×2 topics
  23. Neuroprotection2▲ 8.4×4 topics
  24. Embryonic Stem Cells2▲ 42×2 topics
  25. Transcriptional Regulation2▲ 12×2 topics
  26. Drug Discovery2▲ 7.3×3 topics
  27. Induced Pluripotent Stem Cells2▲ 83×1 topic
  28. Reprogramming2▲ 83×1 topic
  29. Tumor Regression2▲ 34×2 topics
  30. Innate Immunity2▲ 8.0×4 topics
  31. Pathophysiology2▲ 10×4 topics
  32. Traumatic Brain Injury2▲ 27×2 topics
  33. Cytokines2▲ 9.5×5 topics
  34. Hematopoietic Stem Cells2▲ 26×2 topics
  35. Prognosis2▲ 7.9×3 topics
  36. Synaptic Plasticity2▲ 8.5×3 topics
  37. Bone Marrow Niche2▲ 74×1 topic
  38. Cerebral Blood Flow2▲ 27×1 topic
  39. Gene Therapy2▲ 9.2×4 topics
  40. Graft-versus-Host Disease2▲ 74×1 topic

Which research topics does Athersys (United States) publish most on?

By volume in 2022-now: Tissue Engineering and Regenerative Medicine, Mesenchymal stem cell research, Wound Healing and Treatments and Respiratory Support and Mechanisms.

Tissue Engineering and R…0Tissue Engineering and Regenerative Medicine: 0 fractional worksMesenchymal stem cell re…0Mesenchymal stem cell research: 0 fractional worksWound Healing and Treatm…0Wound Healing and Treatments: 0 fractional works
SurgeryGeneticsRehabilitation

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 Tissue Engineering and Regenerative Medicine Surgery 0 works
  2. 2 Mesenchymal stem cell research Genetics 0 works
  3. 3 Wound Healing and Treatments Rehabilitation 0 works
  4. 4 Respiratory Support and Mechanisms Pulmonary and Respiratory Medicine 0 works
  5. 5 Neonatal Respiratory Health Research Pulmonary and Respiratory Medicine 0 works
  6. 6 Immune Response and Inflammation Immunology 0 works

How open and international is its research?

Against the world's own shares: the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available41.4%not open58.6%

World: 40% of research is openly available.

with international co-authors23.0%domestic only77.0%

World: 18% is written across borders.

How has Athersys (United States)'s research output changed?

Output in 2022-2025 was 95% lower than in 2018-2021.

20002005201020152020
grewheldshrank

The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.

Its share of all research

Growing output can still be a shrinking share: all of science grows. This is Athersys (United States) as a percentage of every work published that year, 0.000044% in 2021.

0.00025%0.00050%0.00075%Athersys (United States)0.0000076% in 2023200020102020

Fractional works of Athersys (United States) over all fractional works that year. How the balance of science has shifted.

Other research institutions in Cleveland

All research institutions in Cleveland

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners have tabs of their own, above.

Discussion

Ask a question or share a note about Athersys (United States). Posts are plain text and can be reported.